| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | -13.4% |
| R&D Expense | $28.3M | -26.7% |
| SG&A Expense | $14.0M | -16.3% |
| Operating Income | -$5.7M | +87.2% |
| Income Tax | $0 | — |
| Net Income | -$7.6M | +82.5% |
| EPS (Basic) | -$0.58 | +91.6% |
| EPS (Diluted) | -$0.58 | +91.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | -74.7% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $6.9M | -73.8% |
| Total Assets | $20.0M | -51.6% |
| Current Liabilities | $14.1M | -26.0% |
| Total Liabilities | $14.5M | -69.3% |
| Stockholders' Equity | $5.5M | +191.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.2M | +31.2% |
| Investing Cash Flow | $2.5M | -91.5% |
| Financing Cash Flow | $9.8M | +184.1% |